Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

ANTIPLATELET THERAPY

Novel antibody-based reversal agent for ticagrelor

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

Original article

  1. Bhatt, D. L. et al. Antibody-based ticagrelor reversal agent in healthy volunteers. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa1901778 (2019)

    Article  PubMed  Google Scholar 

Further reading

  1. Levy, J. H. et al. Reversal agents for non-vitamin K antagonist oral anticoagulants. Nat. Rev. Cardiol. 15, 273–281 (2018)

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Karina Huynh.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Huynh, K. Novel antibody-based reversal agent for ticagrelor. Nat Rev Cardiol 16, 320–321 (2019). https://doi.org/10.1038/s41569-019-0191-4

Download citation

Search

Quick links